Role of tamsulosin, solifenacin, and combination therapy in the management of Double J stent related symptoms

Authors

  • Aquinas Benedict*, Vinothkumar Rajenthiran Author

Keywords:

We believe that pharmacologic management is simpler and less invasive than other ways

Abstract

Ureteral stents, which were introduced by Zimskind et al in 1967, are widely used for urinary tract disease.1 The double-J stent, which is the most common form of ureteral stent, is used in obstructive pyelonephritis, intolerable acute renal colic, ureteral edema, ureter perforation following endoscopic procedures, and diseases such as stein- strasse.2,3 Despite the usefulness of stents, however, patients experience various stent-related symptoms, such as pain, frequency and urgency, which cause a significant decrease in patient health-related quality of life (HRQoL).4.

Published

2022-04-30

Issue

Section

Articles